- Home
- ALTS vs STIM Comparison
ALTS vs STIM Comparison
Compare ALTS & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALTS
- STIM
- Stock Information
- Founded
- ALTS 1976
- STIM 2003
- Country
- ALTS United States
- STIM United States
- Employees
- ALTS N/A
- STIM N/A
- Industry
- ALTS
- STIM Medical/Dental Instruments
- Sector
- ALTS
- STIM Health Care
- Exchange
- ALTS NYSE
- STIM Nasdaq
- Market Cap
- ALTS 28.9M
- STIM 29.4M
- IPO Year
- ALTS N/A
- STIM 2018
- Fundamental
- Price
- ALTS $2.15
- STIM $0.84
- Analyst Decision
- ALTS
- STIM Buy
- Analyst Count
- ALTS 0
- STIM 4
- Target Price
- ALTS N/A
- STIM $4.67
- AVG Volume (30 Days)
- ALTS 127.4K
- STIM 801.0K
- Earning Date
- ALTS 11-29-2024
- STIM 11-12-2024
- Dividend Yield
- ALTS N/A
- STIM N/A
- EPS Growth
- ALTS N/A
- STIM N/A
- EPS
- ALTS N/A
- STIM N/A
- Revenue
- ALTS $7,110,000.00
- STIM $72,711,000.00
- Revenue This Year
- ALTS N/A
- STIM $11.40
- Revenue Next Year
- ALTS N/A
- STIM $12.09
- P/E Ratio
- ALTS N/A
- STIM N/A
- Revenue Growth
- ALTS N/A
- STIM 5.03
- 52 Week Low
- ALTS $0.36
- STIM $0.52
- 52 Week High
- ALTS $5.26
- STIM $5.07
- Technical
- Relative Strength Index (RSI)
- ALTS 44.11
- STIM 46.47
- Support Level
- ALTS $2.00
- STIM $0.67
- Resistance Level
- ALTS $2.49
- STIM $0.82
- Average True Range (ATR)
- ALTS 0.24
- STIM 0.13
- MACD
- ALTS -0.05
- STIM -0.02
- Stochastic Oscillator
- ALTS 20.00
- STIM 46.38
About ALTS ALT5 SIGMA CORPORATION
ALT5 Sigma Corp is a fintech company. It is providing next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment and safe-keeping of digital assets. The company product include ALT 5 Prime is an electronic over-the-counter trading platform and ALT 5 Pay crypto payment processor.
About STIM Neuronetics Inc.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.